Error loading player: No playable sources found
4210
Barry Marshall (Nobel Laureate 2005) and Adrienne Marshall Lecture: Latest Advances and Challenges in Helicobacter pylori Screening and Eradication
Date
May 5, 2025
Explore related products in the following collection:
Society: AGA
Chronic Helicobacter pylori (HP) infection is the leading cause of gastric cancer and other adverse outcomes such as peptic ulcer disease. Emerging antibiotic resistance poses a substantial challenge against effective eradication of this organism. This session has two objectives: 1) to evaluate the efficacy of population-based HP screening in reducing gastric cancer incidence globally; 2) to summarize the latest evidence on optimize screening strategies and eradication regimens.
Chronic Helicobacter pylori (HP) infection is the leading cause of gastric cancer and other adverse outcomes such as peptic ulcer disease. Emerging antibiotic resistance poses a substantial challenge against effective eradication of this organism. This session has two objectives: 1) to evaluate the efficacy of population-based HP screening in reducing gastric cancer incidence globally; 2) to summarize the latest evidence on optimize screening strategies and eradication regimens.
Moderators
Brown University
University of Hong Kong Li Ka Shing Faculty of Medicine
